|
Volumn 47, Issue 3, 1997, Pages 259-269
|
Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoi c acid. 4th Communication: Absorption, metabolism, excretion and plasma protein binding in various animals and man
|
Author keywords
Am 80, absorption, excretion, metabolism, subcutaneous administration, topical application; antipsoriatics, topical; CAS 94497 51 5; retinobenzoic acid
|
Indexed keywords
CARBON 14;
DRUG METABOLITE;
RETINOID;
TAMIBAROTENE;
ANIMAL EXPERIMENT;
ARTICLE;
BIOAVAILABILITY;
CONTROLLED STUDY;
DOG;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG FECES LEVEL;
DRUG PROTEIN BINDING;
DRUG URINE LEVEL;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
ISOTOPE LABELING;
MALE;
MOUSE;
RABBIT;
RADIOIMMUNOASSAY;
SUBCUTANEOUS DRUG ADMINISTRATION;
TOPICAL DRUG ADMINISTRATION;
ADMINISTRATION, TOPICAL;
ANIMALS;
BENZOATES;
BIOTRANSFORMATION;
BLOOD PROTEINS;
DOGS;
FEMALE;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
INTESTINAL ABSORPTION;
MALE;
MICE;
MICE, INBRED ICR;
OINTMENTS;
PROTEIN BINDING;
RABBITS;
RATS;
RATS, SPRAGUE-DAWLEY;
RETINOIDS;
SUSPENSIONS;
TETRAHYDRONAPHTHALENES;
|
EID: 8244256655
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (16)
|